ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AVCT Avacta Group Plc

45.50
-1.00 (-2.15%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Avacta Group Plc LSE:AVCT London Ordinary Share GB00BYYW9G87 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -1.00 -2.15% 45.50 45.00 46.00 46.50 44.75 46.50 4,092,357 16:04:09
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 10.06M -39.19M -0.1382 -3.29 129.04M
Avacta Group Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker AVCT. The last closing price for Avacta was 46.50p. Over the last year, Avacta shares have traded in a share price range of 43.25p to 166.50p.

Avacta currently has 283,614,110 shares in issue. The market capitalisation of Avacta is £129.04 million. Avacta has a price to earnings ratio (PE ratio) of -3.29.

Avacta Share Discussion Threads

Showing 79826 to 79846 of 79850 messages
Chat Pages: 3194  3193  3192  3191  3190  3189  3188  3187  3186  3185  3184  3183  Older
DateSubjectAuthorDiscuss
03/5/2024
16:35
Whitey and Tratante ...Batman n Robin.I see the Non- Magnificent 7 are on cracking form. Ps Whitey , why are u STILL here? Another fake leaving post the other day. Have a lovely weekend ...
amanitaangelicus
03/5/2024
16:02
Blue finish
countbasie1
03/5/2024
10:50
AlliancePharma [APH] has an impressive record of long-term growth & creating sustainable value for our shareholders & stakeholders-DIVIDEND +5% -PORTFOLIO BROADENED THROUGH ACQUISITION
blackhorse23
03/5/2024
10:49
Yes mate , money moved to APH
blackhorse23
03/5/2024
09:47
Strong sell.
blueball
02/5/2024
17:41
> Trat ...please dont get too excited by your 7 upticksAman, I'm not at all excited by upticks, indeed I hadn't noticed them. > Enjoy the adulation. I'm certainly not looking for adulation, just giving my alternative opinion in response to your comment - isn't that what the board is for?> Oh yes, you wont be here long like many of the fake lth.s I'm not a fake LTH, I've been in Avacta for long time, since before the LFT was a glimmer in AS's eye. I seldom post as, to be honest, there isn't much useful discussion, mostly people parading egos and slagging each other off. Quod erat demonstrandum!
tratante
01/5/2024
17:07
Doubt it, they would have said so with some words like AS realises the TX division now requires the leadership of a cancer expert and clinician.
tratante
01/5/2024
16:40
Not sure they'd get much for him.!
filthypoor
01/5/2024
16:20
Is the plan that AS goes with the DX division ?
fieldhouse
01/5/2024
16:20
Is the plan that AS goes with the DX division ?
fieldhouse
01/5/2024
15:34
Where do you think he's been exaggerating the data? We got the same messages yesterday from the new CEO, in some cases using the same slides. I agree it's a strange unexplained exit, but not for that reason.
tratante
01/5/2024
13:54
He.ll be selling his share pile like a gd un. Shroomed!
amanitaangelicus
01/5/2024
13:53
When will Smith own up that he.s been exaggerating data? Gone...no fanfare, nothing. Smiths bn found out i reckon. Blagger.
amanitaangelicus
01/5/2024
11:39
With around 18 months of cash, this gives the upper hand to license partners to negotiate hard.
northwards
01/5/2024
10:23
Hand on my heart, I can see this at 25 to 30p within a year
dan_the_epic
01/5/2024
10:08
owf,

A good financial summary. I don't disagree. I think the science is good and i hope the company can now progress asap. The unknown,unknowns are the problem

fieldhouse
01/5/2024
08:33
Better to sell at 44p than nothing in a few months when they come cash calling if they have what they say like any intelligent person this would have been bought out months ago. It's a French Scam
goforgold1
01/5/2024
08:17
Whitey, come back pulease! I.ll give you 24hrs. Good boy. Your dim acolytes are lining the roads.
amanitaangelicus
30/4/2024
20:02
PW

Any other AIM lists it as CEO resigns. Typical Avacta even tried to hide that.

On the point of info to shareholders, Avacta have been probably the most prolific RNS company I’ve seen, constantly spinning anything they can, over and over.

I suspect (if they are to be responsible now), that news events will drop and less spin.

That will better serve shareholders, not this high 5 constant pump that has been going on over far from impressive good data.

Quite clearly Arisaph wanted higher safety and materially better efficacy, which one might expect from concentrated doses.

Results on efficacy are very poor, less than dox original studies.

Glossed up as a game changer.

New hype planned by the look of it but much damage done to avid followers.

Pack the suitcases, get on another flight.

ohwhatfun
30/4/2024
18:17
So they've kicked Smith out and replaced him with Coughlin. I think there's more to this than meets the eye. A whole lot of narrative on her and just a short standard thank you to Smith, almost an afterthought. It will be interesting to see if there's any quicker progress with anything other than what must be the longest Phase 1 trial in history, if there is or a change of direction.
1347
30/4/2024
17:39
Someone happy to buy half a million at 47.2 just after the bell !!
fieldhouse
Chat Pages: 3194  3193  3192  3191  3190  3189  3188  3187  3186  3185  3184  3183  Older

Your Recent History

Delayed Upgrade Clock